Li, Kathy

SARS-CoV-2 evolution during treatment of chronic infection

Kemp, S. A., Collier, D. A., Datir, R. P., Ferreira, I. A. T. M., Gayed, S., Jahun, A., Hosmillo, M., Rees-Spear, C., Mlcochova, P., Lumb, I. U., et al. (2021) · Nature

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,097

Global landscape of HIV–human protein complexes

Jäger, S., Cimermancic, P., Gulbahce, N., Johnson, J. R., McGovern, K. E., Clarke, S. C., Shales, M., Mercenne, G., Pache, L., Li, K., et al. (2012) · Nature

HIV Research and TreatmentAdvanced Proteomics Techniques and Applications

Cited by 731

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Collier, D. A., De Marco, A., Ferreira, I. A. T. M., Meng, B., Datir, R. P., Walls, A. C., Kemp, S. A., Bassi, J., Pinto, D., Silacci-Fregni, C., et al. (2021) · Nature

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 728

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Thomson, E. C., Rosen, L. E., Shepherd, J. G., Spreafico, R., da Silva Filipe, A., Wojcechowskyj, J. A., Davis, C., Piccoli, L., Pascall, D. J., Dillen, J., et al. (2021) · Cell

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 606

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., & Schechter, M. T. (2003) · AIDS

HIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions

Cited by 373

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study

Graham, M. S., Sudre, C. H., May, A., Antonelli, M., Murray, B., Varsavsky, T., Kläser, K., Canas, L. S., Molteni, E., Modat, M., et al. (2021) · The Lancet Public Health

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 304

Safer injection facility use and syringe sharing in injection drug users

Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005) · The Lancet

HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Cited by 294

Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme

Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Hogg, R. S., Montaner, J. S. G., O'Shaughnessy, M. V., & Schechter, M. T. (2002) · AIDS

HIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions

Cited by 146

Impact of HIV Infection on Mortality in a Cohort of Injection Drug Users

Tyndall, M. W., Craib, K. J. P., Currie, S., Li, K., O'Shaughnessy, M. V., & Schechter, M. T. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes

HIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions

Cited by 135

Do Supervised Injecting Facilities Attract Higher-Risk Injection Drug Users?

Wood, E., Tyndall, M. W., Li, K., Lloyd-Smith, E., Small, W., Montaner, J. S. G., & Kerr, T. (2005) · American Journal of Preventive Medicine

HIV, Drug Use, Sexual RiskSubstance Abuse Treatment and Outcomes

Cited by 122

Prevalence and correlates of abscesses among a cohort of injection drug users

Lloyd-Smith, E., Kerr, T., Hogg, R. S., Li, K., Montaner, J. S., & Wood, E. (2005) · Harm Reduction Journal

HIV, Drug Use, Sexual RiskIntramuscular injections and effects

Cited by 102

Substance use and predictors of substance dependence in homeless women

Torchalla, I., Strehlau, V., Li, K., & Krausz, M. (2011) · Drug and Alcohol Dependence

Homelessness and Social IssuesSubstance Abuse Treatment and Outcomes

Cited by 82

The association between childhood maltreatment subtypes and current suicide risk among homeless men and women

Torchalla, I., Strehlau, V., Li, K., Schuetz, C., & Krausz, M. (2012) · Child Maltreatment

Child Abuse and TraumaSuicide and Self-Harm Studies

Cited by 57